Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Total Revenue

Gilead Sciences Inc Total Revenue Chart (GILD)

Gilead Sciences Inc annual/quarterly Total Revenue from 2010 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Gilead Sciences Inc Total Revenue for the quarter ending September 09, 2020 was $6,577m a 10.61% increase of 698m year over year
  • Gilead Sciences Inc Total Revenue for the last 12 months ending September 09, 2020 was $23,147m a 3.02% increase of 698m year over year
  • Gilead Sciences Inc Annual Total Revenue for 2019 was $22,449m a 1.43% increase of 322m from 2018
  • Gilead Sciences Inc Annual Total Revenue for 2018 was $22,127m a -17.99% decrease of -3,980m from 2017
  • Gilead Sciences Inc Annual Total Revenue for 2017 was $26,107m a -16.41% decrease of -4,283m from 2016
Other Income Statement Metrics:
  • Gilead Sciences Inc EBITDA for the quarter ending December 12, 2018 was $1,502m a -67.11% decrease of -1,008m year over year
  • Gilead Sciences Inc Net Income for the quarter ending December 12, 2018 was $3m a -51,166.67% decrease of -1,535m year over year
View Chart On Koyfin

Quarterly GILD Total Revenue Data

09/2020$6,577m
06/2020$5,143m
03/2020$5,548m
12/2019$5,879m
09/2019$5,604m
06/2019$5,685m
03/2019$5,281m
12/2018$5,795m
09/2018$5,596m
06/2018$5,648m

Annual GILD Total Revenue Data

2019$22,449m
2018$22,127m
2017$26,107m
2016$30,390m
2015$32,639m
2014$24,890m
2013$11,202m
2012$9,702m
2011$8,385m
2010$7,949m